×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for ...
Yahoo Finance
Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed Significant clinical trial burden and costs...
5 days ago
Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds
BioSpace
Published: May 09, 2024 By Tristan Manalac. Cell therapy_iStock, Maksim Tkachenko. Pictured: 3D illustration of stem cells used for cell therapy/iStock,...
2 weeks ago
Lisata treats first patient in Phase IIa trial of LSTA1 drug
Clinical Trials Arena
Lisata Therapeutics Inc · View all. The placebo-controlled, double-blind, randomised, proof-of-concept trial aims to evaluate LSTA1 when...
4 months ago
Lisata Therapeutics receives PIP waiver from EMA for certepetide - TipRanks.com
Tipranks
Lisata Therapeutics announced that it has reached agreement with the European Medicines Agency, EMA, on a Paediatric Investigation Plan, PIP, for Lisata's...
3 days ago
Lisata Therapeutics receives waiver for pediatric studies of certepetide in pancreatic cancer
Proactive financial news
Lisata Therapeutics Inc (NASDAQ:LSTA) has received a Paediatric Investigation Plan (PIP) waiver from the European Medicines Agency (EMA) for...
5 days ago
EMA grants waiver for Lisata's pediatric pancreatic cancer studies
Investing.com
BASKING RIDGE, N.J. - Lisata Therapeutics, Inc. (NASDAQ:LSTA), a clinical-stage pharmaceutical company, has announced that the European...
5 days ago
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Yahoo Finance
Seminal Phase 2b ASCEND trial top-line data expected in fourth quarter of 2024 Projected available cash to fund planned operations into...
2 weeks ago
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
GlobeNewswire
BASKING RIDGE, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
2 weeks ago
Earnings call: Lisata Therapeutics reports Q1 progress on cancer drug By Investing.com
Investing.com
Lisata Therapeutics (ticker not provided) has reported significant advancements in its first quarter of 2024 earnings call regarding the...
2 weeks ago
Lisata Therapeutics Net Loss Declines From a Year Earlier
Yahoo Finance
By Daniella Parra Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company, said its net loss was $5.4 million for...
2 weeks ago